- Home
- A-Z Publications
- Current Drug Safety
- Previous Issues
- Volume 14, Issue 1, 2019
Current Drug Safety - Volume 14, Issue 1, 2019
Volume 14, Issue 1, 2019
-
-
Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review
Authors: Ahmed Abbas and Yusuf A. Rajabally.Background: Intravenous Immunoglobulin (IVIg) forms a cornerstone of effective treatment for acute and chronic inflammatory neuropathies, with a class I evidence base in Guillain-Barré Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and multifocal motor neuropathy (MMN). It is generally considered to be a safe therapy however there are several recognised complications which are review Read More
-
-
-
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Summarized Overview
Authors: Kerasia-Maria Plachouri, Eleftheria Vryzaki and Sophia GeorgiouBackground: The introduction of Immune Checkpoint Inhibitors in the recent years has resulted in high response rates and extended survival in patients with metastatic/advanced malignancies. Their mechanism of action is the indirect activation of cytotoxic T-cells through the blockade of inhibitory receptors of immunomodulatory pathways, such as cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), programmed cell d Read More
-
-
-
Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Authors: Viswam Subeesh, Eswaran Maheswari, Hemendra Singh, Thomas E. Beulah and Ann Mary SwaroopBackground: The signal is defined as “reported information on a possible causal relationship between an adverse event and a drug, of which the relationship is unknown or incompletely documented previously”. Objective: To detect novel adverse events of iloperidone by disproportionality analysis in FDA database of Adverse Event Reporting System (FAERS) using Data Mining Algorithms (DMAs). Methodology: The US FAERS Read More
-
-
-
Comparison of the Effects of Metoprolol and Bisoprolol on Lipid and Glucose Profiles in Cardiovascular Patients
Authors: Ahmad A. Almeman, Yasir Ahmed Beshir and Ahmad Hamad AldosaryBackground: Cardioselective beta-blockers may affect glucose or lipid profiles. Objective: We sought to compare the effects of two beta-blockers, metoprolol and bisoprolol, as the most commonly used drugs in cardiology, on glucose and lipid profiles in patients with cardiovascular diseases. Methods: We conducted a retrospective cross-sectional matched study at Prince Sultan Cardiac Center in Burydah in August 2017. Patie Read More
-
-
-
Safety of Vinflunine in Patients with Advanced Urothelial Carcinoma Refractory to Platinum-based Chemotherapy: A Prospective Pilot Study
Background: Several single chemotherapeutic agents have been evaluated as the second-line treatment of advanced urothelial carcinoma. Despite encouraging efficacy outcomes, toxicity has often led to dose modifications or discontinuation. We aimed to assess the safety of vinflunine in a particular population of advanced transitional cell carcinoma of urothelium (TCCU), that were exposed to the previous toxicity of chemot Read More
-
-
-
Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report
More LessBackground: Dapsone is a sulfone derived drug used in the treatment of leprosy and several chronic inflammatory dermatological diseases. Dapsone Hypersensitivity Syndrome (DHS) is characterized by fever, hepatitis, generalized exfoliative dermatitis and lymphadenopathy. It is rare and potentially fatal. Case Report: We present a case report of a 52 years old female with a recent history of antecedent dapsone expos Read More
-
-
-
Dabigatran Reversal with Idarucizumab in an Emergency Lumbar Puncture: A Case Report
Introduction: The widespread use of direct oral anticoagulants (DOACs) has been increasing the conditions in which emergency physicians are forced to rapidly reverse anticoagulation in case of life-threatening bleeding or need of urgent surgery or invasive procedures. The recent approval of Idarucizumab, a humanized monoclonal antibody fragment (Fab), offered the opportunity to rapidly and safely neutralize the anticoag Read More
-
-
-
Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory
Authors: M. Kanakis, I. Georgalas, T. Makatsoris and N. PharmakakisPurpose: To report a case of a 73-year-old man who presented with decreased visual acuity due to bilateral macular edema after paclitaxel administration for prostate cancer. Methods: The ophthalmic evaluation consisted of medical and ocular history, Best Corrected Visual Acuity, slit-lamp biomicroscopy and Spectral-domain optical coherence tomography / Fluorescein Angiography. Results: Optical Coherence Tomogra Read More
-
-
-
Biperiden-Induced Delirium In A Five-Years Old Child
Authors: Duygu Kınay and Ahmet Z. SoyataObjective: Extrapyramidal adverse effects of antipsychotic drugs are more reported in children. Biperiden is an anticholinergic agent to treat the adverse effects of antipsychotic drugs. The drug has the potential to induce delirium at toxic doses. However, data are scarce about delirium associated with biperiden in children. Thus far, a case of delirium has been associated with biperiden in an adolescent patient. We report Read More
-
-
-
Phenytoin Induced Chorea: A Rare Adverse Effect of the Drug
More LessBackground: Dyskinetic neurological diseases are common presentations of adverse reaction to many therapeutic agents. Phenytoin, a widely used age-old antiepileptic drug has been reported to cause dyskinesias, a rare Adverse Drug Reaction (ADR) in adults with toxic therapeutic serum level. When the drug is used in combination with other drugs which augments free drug level of phenytoin or in patients of organic brain lesio Read More
-
-
-
Report of Adverse Events in Colombia: A Successful Case
Authors: Ornella Moreno-Mattar, Rosana Ramírez, Andrés Alvarado, Francisco Sierra and Javier GuzmánBackground: The Colombian National Food and Drug Surveillance Institute (INVIMA) is responsible for monitoring the safety and efficacy of medicines circulating the Colombian market. Discussion: This article summarizes the three key strategies the institution has implemented to strengthen the National Pharmacovigilance Program: improving the interaction and working relationship with regional health authorities, Read More
-
-
-
Cardiotoxicity Associated with Midazolam in a Patient with Diphtheria
Authors: Jayendra R. Gohil and Sonal JindalBackground: Adverse cardiorespiratory events are associated with midazolam continuous IV infusion, used for sedation. History: Here we are reporting a case of 5 year old male child suffering from diphtheria induced airway obstruction, and myocarditis, who received midazolam in the form of IV infusion for sedation while undergoing mechanical ventilation for respiratory failure. Adverse Event: Six hours after starting m Read More
-
-
-
Delayed Hemolytic Anemia after Treatment with Artesunate: Case Report and Literature Review
Background: In recent years, few cases of post-artemisinin delayed hemolysis have been reported. Objective: All cases of post-artemisinin delayed hemolysis were reported from non-middle east areas. No case of post-artemisinin delayed hemolysis has yet been reported from this region. In this paper, we describe a case of post-artemisinin delayed hemolysis in an Iranian female. Moreover, previous reports have been reviewed. Read More
-
-
-
Glecaprevir/Pibrentasvir Induced Cholestatic Jaundice in a HCV Patient with Renal Failure. A Case Presentation
Background: Direct-acting Antivirals (DAA) are currently used in the treatment of chronic HCV infection. In patients with renal failure Glecaprevir/Pibrentasvir (genotype 1-6) is recommended for its safety and efficacy. Case Presentation: Although these pharmacological characteristics, an adverse drug reaction (ADR) has been reported during Glecaprevir/Pibrentasvir treatment, such as the development Read More
-
-
-
Norfloxacin Induced Recurrent Fixed Drug Eruption in a self Treated Adult Female Patient - A Case Report
Authors: Singh Vikramjeet, Batta Angelika and Malik NishthaBackground: Fixed drug eruption is a clinical entity occurring at the same site each time the drug is administered. They are usually found on lips, genitalia, abdomen, and legs but can occur at any location. The eruptions usually occur within hours of administration of the drug and resolves spontaneously. Most common drugs causing them include antimicrobials. Fluroquinolones especially norfloxacin is commonly used in the Read More
-
-
-
Plantar Psoriasis Associated with Olmesartan
Authors: Ons Charfi, Talel Badri, Ghozlane Lakhoua, Sarrah Kastalli, Sihem El Aidli and Ahmed ZaïemBackground: Psoriasis is a chronic inflammatory skin disorder that may be initiated or exacerbated by some drug intakes. Some of the most common medications known to trigger or worsen existing psoriasis include lithium, gold salts, beta blockers and antimalarials. Conclusion: We report an exceptional case of plantar psoriasis in a woman who was treated by olmesartan for 3 years.
-
-
-
Safety of a Clozapine Trial Following Quetiapine-Induced Leukopenia: A Case Report
More LessBackground: The clozapine-derivative quetiapine has been shown in some cases to cause leukopenia and neutropenia. Case Presentation: We reported on a case of a young female diagnosed with treatment-resistant schizophrenia. After failed trials of three antipsychotic medications and despite a history of quetiapineinduced leukopenia, clozapine treatment was introduced due to the severity of the patient's symptoms, th Read More
-
Volumes & issues
-
Volume 20 (2025)
-
Volume 19 (2024)
-
Volume 18 (2023)
-
Volume 17 (2022)
-
Volume 16 (2021)
-
Volume 15 (2020)
-
Volume 14 (2019)
-
Volume 13 (2018)
-
Volume 12 (2017)
-
Volume 11 (2016)
-
Volume 10 (2015)
-
Volume 9 (2014)
-
Volume 8 (2013)
-
Volume 7 (2012)
-
Volume 6 (2011)
-
Volume 5 (2010)
-
Volume 4 (2009)
-
Volume 3 (2008)
-
Volume 2 (2007)
-
Volume 1 (2006)
Most Read This Month
Article
content/journals/cds
Journal
10
5
false
en
